Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Kelly

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
JCO Precision Oncology|April 10, 2025
<i>BRCA1/2</i> and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study AnalysisEric Hahnen, Jan Hauke, Karen Gelmon, et al.
The New England Journal of Medicine|December 16, 2021
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast CancerKevin Kalinsky, William E Barlow, Julie R Gralow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2026
Clinical and Molecular Evaluation of HER2-Low and Ultralow Breast Cancer in the PENELOPE-B Clinical Trial CohortCarsten Denkert, Sivaramakrishna Rachakonda, Anika Pehl, et al.
Cancer Cell|February 11, 2025
Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtypingCarsten Denkert, Sivaramakrishna Rachakonda, Thomas Karn, et al.
Breast Cancer Research and Treatment|June 14, 2021
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national studyLisa Prior, Richard O'Dwyer, Abdul Rehman Farooq, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
JCO Precision Oncology|April 10, 2025
<i>BRCA1/2</i> and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study AnalysisEric Hahnen, Jan Hauke, Karen Gelmon, et al.
The New England Journal of Medicine|December 16, 2021
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast CancerKevin Kalinsky, William E Barlow, Julie R Gralow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2026
Clinical and Molecular Evaluation of HER2-Low and Ultralow Breast Cancer in the PENELOPE-B Clinical Trial CohortCarsten Denkert, Sivaramakrishna Rachakonda, Anika Pehl, et al.
Cancer Cell|February 11, 2025
Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtypingCarsten Denkert, Sivaramakrishna Rachakonda, Thomas Karn, et al.
Breast Cancer Research and Treatment|June 14, 2021
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national studyLisa Prior, Richard O'Dwyer, Abdul Rehman Farooq, et al.
Pageof 7